EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Emerging role of sirtuins in non‑small cell lung cancer (Review)

Min Zhou, Lin Wei, Renfu Lu

Oncology Reports · 30.07.2024 · 52 (4)

DOI: 10.3892/or.2024.8786 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 30.07.2024. Verfasst von Min Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Chongqing University Central Hospital, Chongqing 400014, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Sirtuins, Lung Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‑small cell lung cancer (NSCLC) is a highly prevalent lung malignancy characterized by insidious onset, rapid progression and advanced stage at the time of diagnosis, making radical surgery impossible. Sirtuin (SIRT) is a histone deacetylase that relies on NAD+ for its function, regulating the aging process through modifications in protein activity and stability. It is intricately linked to various processes, including glycolipid metabolism, inflammation, lifespan regulation, tumor formation and stress response. An increasing number of studies indicate that SIRTs significantly contribute to the progression of NSCLC by regulating pathophysiological processes such as energy metabolism, autophagy and apoptosis in tumor cells through the deacetylation of histones or non‑histone proteins. The present review elaborates on the roles of different SIRTs and their mechanisms in NSCLC, while also summarizing novel therapeutic agents based on SIRTs. It aims to present new ideas and a theoretical basis for NSCLC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungSirtuinsLung NeoplasmsHumansAutophagyApoptosisEnergy Metabolism

Stichwörter der Autor:innen

NAD+apoptosisautophagyhistone deacetylasenon‑small cell lung cancersirtuins

Substanzen

Sirtuins

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Chongqing University Central Hospital, Chongqing 400014, P.R. China.

Zitieren

APA

Zhou, M., Wei, L., & Lu, R. (2024). Emerging role of sirtuins in non‑small cell lung cancer (Review). Oncology Reports, 52(4). https://doi.org/10.3892/or.2024.8786

Vancouver

Zhou M, Wei L, Lu R. Emerging role of sirtuins in non‑small cell lung cancer (Review). Oncology Reports. 2024;52(4). doi:10.3892/or.2024.8786

BibTeX
@article{Zhou2024,
  author = {Zhou, Min and Wei, Lin and Lu, Renfu},
  title = {Emerging role of sirtuins in non‑small cell lung cancer (Review)},
  journal = {Oncology Reports},
  year = {2024},
  volume = {52},
  number = {4},
  doi = {10.3892/or.2024.8786}
}
Kostenlos starten →